试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-16
Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment
编号:NCT01495208登记状态:入组前撤回企业 / 申办者:Vitreous -Retina- Macula Consultants of New York
药物 / 成分:Aflibercept
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-16
A Phase Ib Study of NVX-508 in Sickle Cell Disease
编号:NCT03013426登记状态:入组前撤回企业 / 申办者:Amma Owusu-Ansah, MD
药物 / 成分:NVX-508
登记的停止原因(原文):NuvOx Pharma suspended the clinical program related to this study.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-13
Effect of Levobupivacaine Infiltration on the Post Partum Perineal Pain in Episiotomy, in Primiparous Women After Instrumental Delivery
编号:NCT02796547登记状态:入组前撤回企业 / 申办者:Brugmann University Hospital
药物 / 成分:Levobupivacaine、Physiological serum
登记的停止原因(原文):Lack of human ressources
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-13
A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach
编号:NCT02943603登记状态:入组前撤回企业 / 申办者:Weijing Sun, MD, FACP
药物 / 成分:mFLOFOX6 + pembrolizumab
登记的停止原因(原文):No participants enrolled. PI/Sponsor left UPitt. IND withdrawn \& revised protocol submitted through the new institution. New study recruiting under NCT03488667.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-12
Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene
编号:NCT00386399登记状态:入组前撤回企业 / 申办者:Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
药物 / 成分:Mitomycin-C
登记的停止原因(原文):All consented subjects tested negative for the BRCA2 mutation, therefore, did not meet criteria to start the study, resulting in withdrawal by PI
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-12
Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use
编号:NCT02522936登记状态:入组前撤回企业 / 申办者:University of Southern California
药物 / 成分:Biotene oral spray
登记的停止原因(原文):Due to lack of funding and necessary personnel we determined that the study could not be done.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-11
Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis
编号:NCT02795299登记状态:入组前撤回企业 / 申办者:Bird Rock Bio, Inc.
药物 / 成分:Gerilimzumab、Methotrexate、Folic Acid、Placebo
登记的停止原因(原文):Study not started due to Sponsor decision to not move forward with compound.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-10
Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
编号:NCT02724150登记状态:入组前撤回企业 / 申办者:Damascus Hospital
药物 / 成分:Omeprazole High dose、Omeprazole Low dose
登记的停止原因(原文):No participants enrolled
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-06
Pediatric Atopic Dermatitis (AD) Internet Survey
编号:NCT01385527登记状态:入组前撤回企业 / 申办者:Wake Forest University
药物 / 成分:Weekly Internet survey、Topical Triamcinolone
登记的停止原因(原文):study was never initiated, No participants enrolled
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-07-05
E-Selectin Nasal Instillation to Prevent Secondary Stroke
编号:NCT00069069登记状态:入组前撤回企业 / 申办者:National Institute of Neurological Disorders and Stroke (NINDS)
药物 / 成分:Intransal instillation of E-selectin
查看官方原始记录 ↗